Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the “Company”) announces the closing of a previously announced private…
TORONTO–(BUSINESS WIRE)–#FSDDF–FSD Pharma Inc. (NASDAQ: HUGE) (“FSD Pharma” or the “Company”), today announced it has entered into definitive agreements with…
FDA allowed FSD Pharma to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
FSD Pharma, World-Class Extractions inc have formed a Joint Venture to develop, manage and operate cannabis extraction and processing center at FSD Pharma Facility in Cobourg, Ontario.
FSD acquires platform company to advance R&D of targeted application of micro-Palmitoylethanolamide impacting the human endocannabinoid system
FSD Pharma delays 2018 Year-End Filings, working with new auditing firm in advance of listing on the NYSE
The license allows the current FSD facility to supply and sell cannabisproducts. The company expects receiving the amended sales licensethat will include the sale of dried and fresh cannabis flower in thenear future.
TORONTO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/FSDDF?src=hash” target=”_blank”gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the appointment…